“LGALS3 +191A and +292C polymorphisms are associated with a reduction in serum gal-3 levels, but not with the clinical events of individuals with sickle cell anemia” (2020) Research, Society and Development, 9(9), p. e442997314. doi:10.33448/rsd-v9i9.7314.